Sancy A. Leachman, MD, PhD
Director, Melanoma and Cutaneous Oncology Program
Director and Principal Investigator, Tom C. Mathews Jr. Familial Melanoma Research Clinic
Professor, Department of Dermatology
Sancy Leachman, MD, PhD, is director of the Melanoma and Cutaneous Oncology Program, a professor in the Department of Dermatology at the University of Utah School of Medicine, and member of the Imaging, Diagnostics, and Therapeutics Program and the Cancer Control and Population Sciences Program. She is a dermatologist using basic science research and state-of-the-art technology to combat skin cancer.
Leachman examines the role of genetic predisposition and differential gene expression in the development of melanoma, with an emphasis on the familial melanoma syndrome. Through her investigations, she hopes to develop agents that will serve as diagnostic tools, prognostic indicators, or targeted agents for the prevention of melanoma. Her clinical interests include skin cancers, especially melanoma, pigmentary disorders that result from abnormalities of melanocytes such as vitiligo, and genetic disorders that involve the skin such as pachyonychia congenita, Cowden syndrome, and other cutaneous cancer syndromes.
Leachman was a key figure in developing the multidisciplinary melanoma program at Huntsman Cancer Institute and now serves as director of the program. The program brings together researchers and physicians with an interest in melanoma and other skin cancers in order to bring knowledge and expertise from the laboratory into the clinical realm. By applying the latest scientific technology to the problem of human cancer, Leachman and her colleagues strive to improve the medical community's ability to diagnose and treat skin cancers.
Before joining Huntsman Cancer Institute, Leachman was a resident and fellow in dermatology at the Yale University School of Medicine, where she worked on a DNA vaccination study to prevent and treat papillomavirus-induced squamous cell carcinoma. She earned her MD and PhD from the University of Texas Southwestern Medical School, and was awarded the prestigious Doris Duke Clinical Scientist Development Award in 2000.